User profiles for Lyduine E. Collij

Lyduine Collij

Postdoc researcher Neurosciences, Lund University
Verified email at amsterdamumc.nl
Cited by 920

[HTML][HTML] Quantification of amyloid PET for future clinical use: a state-of-the-art review

HG Pemberton, LE Collij, F Heeman, A Bollack… - European journal of …, 2022 - Springer
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s
disease (AD) pathogenesis. The overall load and spatial distribution of brain Aβ can be …

Association of CSF, plasma, and imaging markers of neurodegeneration with clinical progression in people with subjective cognitive decline

…, KA van den Bosch, M van Leeuwenstijn, LE Collij… - Neurology, 2022 - AAN Enterprises
Background and Objectives Multiple biomarkers have been suggested to measure
neurodegeneration (N) in the AT(N) framework, leading to inconsistencies between studies. We …

[HTML][HTML] A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the …

…, LE Collij, M Scherer, E Morenas-Rodriguez… - Acta …, 2019 - Springer
The genetic variant rs72824905-G (minor allele) in the PLCG2 gene was previously
associated with a reduced Alzheimer’s disease risk (AD). The role of PLCG2 in immune system …

Spatial-temporal patterns of β-amyloid accumulation: a subtype and stage inference model analysis

LE Collij, G Salvadó, V Wottschel, SE Mastenbroek… - Neurology, 2022 - AAN Enterprises
Background and Objectives β-amyloid (Aβ) staging models assume a single spatial-temporal
progression of amyloid accumulation. We assessed evidence for Aβ accumulation …

Multitracer model for staging cortical amyloid deposition using PET imaging

LE Collij, F Heeman, G Salvadó, S Ingala, D Altomare… - Neurology, 2020 - AAN Enterprises
Objective To develop and evaluate a model for staging cortical amyloid deposition using
PET with high generalizability. Methods Three thousand twenty-seven individuals (1,763 …

clinical effect of early vs late amyloid positron emission tomography in memory clinic patients: the AMYPAD-DPMS randomized clinical trial

D Altomare, F Barkhof, C Caprioglio, LE Collij… - JAMA …, 2023 - jamanetwork.com
Importance Amyloid positron emission tomography (PET) allows the direct assessment of
amyloid deposition, one of the main hallmarks of Alzheimer disease. However, this technique …

Application of machine learning to arterial spin labeling in mild cognitive impairment and Alzheimer disease

LE Collij, F Heeman, JPA Kuijer, R Ossenkoppele… - Radiology, 2016 - pubs.rsna.org
Purpose To investigate whether multivariate pattern recognition analysis of arterial spin
labeling (ASL) perfusion maps can be used for classification and single-subject prediction of …

[HTML][HTML] The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact

LE Collij, G Farrar, D Valléz García, I Bader… - Frontiers in …, 2023 - frontiersin.org
Background Amyloid-β (Aβ) accumulation is considered the earliest pathological change in
Alzheimer's disease (AD). The Amyloid Imaging to Prevent Alzheimer's Disease (AMYPAD) …

Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid Immunotherapies

N Mattsson-Carlgren, LE Collij, E Stomrud… - JAMA …, 2024 - jamanetwork.com
Importance Antiamyloid immunotherapies against Alzheimer disease (AD) are emerging.
Scalable, cost-effective tools will be needed to identify amyloid β (Aβ)–positive patients without …

Assessing amyloid pathology in cognitively normal subjects using 18F-flutemetamol PET: comparing visual reads and quantitative methods

LE Collij, E Konijnenberg, J Reimand… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Our objective was to determine the optimal approach for assessing amyloid disease in a
cognitively normal elderly population. Methods: Dynamic 18 F-flutemetamol PET scans were …